Cargando…
Minor contribution of cytochrome P450 3A activity on fentanyl exposure in palliative care cancer patients
Transdermal fentanyl is widely used to control pain in cancer patients. The high pharmacokinetic variability of fentanyl is assumed to be due to cytochrome P450 3A-mediated (CYP3A) N-dealkylation to norfentanyl in humans. However, recently published clinical studies question the importance of the de...
Autores principales: | Geist, Marcus J. P., Ziesenitz, Victoria C., Bardenheuer, Hubert J., Burhenne, Juergen, Skopp, Gisela, Mikus, Gerd |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6786992/ https://www.ncbi.nlm.nih.gov/pubmed/31601999 http://dx.doi.org/10.1038/s41598-019-51279-6 |
Ejemplares similares
-
Oral Yohimbine as a New Probe Drug to Predict CYP2D6 Activity: Results of a Fixed-Sequence Phase I Trial
por: Vay, Manuela, et al.
Publicado: (2020) -
Pharmacokinetics of a microdosed cocktail of three direct oral anticoagulants in children with congenital heart defects: study protocol for a single-centre clinical trial (DOAC-Child)
por: Hermann, Simon A, et al.
Publicado: (2023) -
Cytochrome P450 humanised mice
por: Gonzalez, Frank J
Publicado: (2004) -
The Cytochrome P450 Homepage
por: Nelson, David R
Publicado: (2009) -
Probing the Role of the Hinge Segment of Cytochrome P450 Oxidoreductase in the Interaction with Cytochrome P450
por: Campelo, Diana, et al.
Publicado: (2018)